Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma? View Full Text


Ontology type: schema:ScholarlyArticle     

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/ncpuro0183

DOI

http://dx.doi.org/10.1038/ncpuro0183

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010049560


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Associate Professor of Urology and Director of the Renal Cell Carcinoma Working Group at the University of Texas MD Anderson Cancer Center in Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Associate Professor of Urology and Director of the Renal Cell Carcinoma Working Group at the University of Texas MD Anderson Cancer Center in Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wood", 
        "givenName": "Christopher G", 
        "id": "sg:person.01040121722.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2005-05", 
    "datePublishedReg": "2005-05-01", 
    "genre": "article", 
    "id": "sg:pub.10.1038/ncpuro0183", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1034152", 
        "issn": [
          "1759-4812", 
          "1759-4820"
        ], 
        "name": "Nature Reviews Urology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "2"
      }
    ], 
    "keywords": [
      "high-dose interleukin-2", 
      "metastatic renal cell carcinoma", 
      "renal cell carcinoma", 
      "outpatient regimens", 
      "cell carcinoma", 
      "interleukin-2", 
      "regimens", 
      "carcinoma"
    ], 
    "name": "Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma?", 
    "pagination": "218-219", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010049560"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/ncpuro0183"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/ncpuro0183", 
      "https://app.dimensions.ai/details/publication/pub.1010049560"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_408.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/ncpuro0183"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ncpuro0183'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ncpuro0183'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ncpuro0183'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ncpuro0183'


 

This table displays all metadata directly associated to this object as RDF triples.

64 TRIPLES      19 PREDICATES      32 URIs      24 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/ncpuro0183 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N2c91fd3612ce4a55a898608d95449bed
4 schema:datePublished 2005-05
5 schema:datePublishedReg 2005-05-01
6 schema:genre article
7 schema:isAccessibleForFree false
8 schema:isPartOf Na533178641894dfd92d4ba9f39fb3833
9 Nbe674efa967f4ab2a0e9df7c55c89114
10 sg:journal.1034152
11 schema:keywords carcinoma
12 cell carcinoma
13 high-dose interleukin-2
14 interleukin-2
15 metastatic renal cell carcinoma
16 outpatient regimens
17 regimens
18 renal cell carcinoma
19 schema:name Can high-dose interleukin-2 be replaced with lower-dose, outpatient regimens for metastatic renal cell carcinoma?
20 schema:pagination 218-219
21 schema:productId Nf9801f6489754a8084499965547d6550
22 Nfd6f4d9ca6754d1db45040d392d98d81
23 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010049560
24 https://doi.org/10.1038/ncpuro0183
25 schema:sdDatePublished 2022-10-01T06:33
26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
27 schema:sdPublisher Nb762f94ede12433cb9eff003c225bb89
28 schema:url https://doi.org/10.1038/ncpuro0183
29 sgo:license sg:explorer/license/
30 sgo:sdDataset articles
31 rdf:type schema:ScholarlyArticle
32 N2c91fd3612ce4a55a898608d95449bed rdf:first sg:person.01040121722.56
33 rdf:rest rdf:nil
34 Na533178641894dfd92d4ba9f39fb3833 schema:issueNumber 5
35 rdf:type schema:PublicationIssue
36 Nb762f94ede12433cb9eff003c225bb89 schema:name Springer Nature - SN SciGraph project
37 rdf:type schema:Organization
38 Nbe674efa967f4ab2a0e9df7c55c89114 schema:volumeNumber 2
39 rdf:type schema:PublicationVolume
40 Nf9801f6489754a8084499965547d6550 schema:name doi
41 schema:value 10.1038/ncpuro0183
42 rdf:type schema:PropertyValue
43 Nfd6f4d9ca6754d1db45040d392d98d81 schema:name dimensions_id
44 schema:value pub.1010049560
45 rdf:type schema:PropertyValue
46 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
47 schema:name Medical and Health Sciences
48 rdf:type schema:DefinedTerm
49 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
50 schema:name Clinical Sciences
51 rdf:type schema:DefinedTerm
52 sg:journal.1034152 schema:issn 1759-4812
53 1759-4820
54 schema:name Nature Reviews Urology
55 schema:publisher Springer Nature
56 rdf:type schema:Periodical
57 sg:person.01040121722.56 schema:affiliation grid-institutes:grid.240145.6
58 schema:familyName Wood
59 schema:givenName Christopher G
60 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040121722.56
61 rdf:type schema:Person
62 grid-institutes:grid.240145.6 schema:alternateName Associate Professor of Urology and Director of the Renal Cell Carcinoma Working Group at the University of Texas MD Anderson Cancer Center in Houston, TX, USA
63 schema:name Associate Professor of Urology and Director of the Renal Cell Carcinoma Working Group at the University of Texas MD Anderson Cancer Center in Houston, TX, USA
64 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...